61 /100
HIGH RISK
Score updated Jul 14, 2026

XFOR — X4 Pharmaceuticals, Inc. Dilution Risk Tracker

Track XFOR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track XFOR — Get alerts when the score changes →

As of July 14, 2026, X4 Pharmaceuticals, Inc. (XFOR) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. X4 Pharmaceuticals, Inc. has a market capitalization of $406.52M, 94.32M shares outstanding, 82 institutional holders tracked. Key dilution vectors include 15.24M outstanding warrants, approximately 20 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
25
📊 Float Risk
30
⚠️ Warrant Exposure
50
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
📜 Warrant Exercise 25%
• Significant warrants: 16% of shares outstanding
📉 Score Deterioration 10%
• Score in HIGH risk zone (61/100)
🔔 Track XFOR — Get forecast alerts →

💹 Market Data

Market Cap$406.52M
Shares Outstanding94.32M
Float57.41M
Cash$216.91M
Debt$54.57M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 34.0% shares (2026Q1 vs prior)
82 institutional holders · 115.29M shares
#1 MORGAN STANLEY 17.68M shares
#2 PERCEPTIVE ADVISORS LLC 13.48M shares
#3 Empery Asset Management, LP 8.94M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest5.51M
Days to Cover3.5
% of Float9.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for XFOR Shareholders

X4 Pharmaceuticals, Inc. (XFOR) has a DilutionScore of 61/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch tracks 15.2M outstanding warrants for XFOR. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for XFOR in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for XFOR alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track XFOR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XFOR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for XFOR
📊 XFOR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XFOR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.